Cargando…
An Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity
Anthracycline-based cardiotoxicity is concerning for women with breast cancer and portends a dose-dependent risk of developing left ventricular dysfunction. Overall, the prevalence of heart failure (HF) is ≈2% of the total US population; however, BRCA-deficient mice have shown increased HF. We evalu...
Autores principales: | Sajjad, Monique, Fradley, Michael, Sun, Weihong, Kim, Jongphil, Zhao, Xiuhua, Pal, Tuya, Ismail-Khan, Roohi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333048/ https://www.ncbi.nlm.nih.gov/pubmed/28157161 http://dx.doi.org/10.3390/genes8020059 |
Ejemplares similares
-
Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers
por: Kumar, Nagi B., et al.
Publicado: (2012) -
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017) -
Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007) -
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007) -
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)